119 related articles for article (PubMed ID: 11150580)
1. Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin.
Hansen JB; Svensson B; Sandset PM; Thijssen F
Thromb Res; 2000 Dec; 100(5):389-96. PubMed ID: 11150580
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy.
Hansen JB; Sandset PM
Thromb Res; 1998 Aug; 91(4):177-81. PubMed ID: 9736420
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor release induced by defibrotide and heparins.
Cella G; Sbarai A; Mazzaro G; Motta G; Carraro P; Andreozzi GM; Hoppensteadt DA; Fareed J
Clin Appl Thromb Hemost; 2001 Jul; 7(3):225-8. PubMed ID: 11441984
[TBL] [Abstract][Full Text] [Related]
4. The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.
Holst J; Lindblad B; Bergqvist D; Hedner U; Nordfang O; Ostergaard P
Thromb Res; 1997 May; 86(4):343-8. PubMed ID: 9187023
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. possible implications for measurements in vivo after heparin therapy.
Bladbjerg EM; Larsen LF; Ostergaard P; Jespersen J
Blood Coagul Fibrinolysis; 2000 Dec; 11(8):739-45. PubMed ID: 11132652
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action.
Hansen JB; Sandset PM; Huseby KR; Huseby NE; Bendz B; Ostergaard P; Nordøy A
Br J Haematol; 1998 Jun; 101(4):638-46. PubMed ID: 9674734
[TBL] [Abstract][Full Text] [Related]
7. A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1.
Bendz B; Andersen TO; Sandset PM
Thromb Res; 2000 Mar; 97(6):463-72. PubMed ID: 10704656
[TBL] [Abstract][Full Text] [Related]
8. Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa.
Martínez-Martínez I; Ordóñez A; Pedersen S; de la Morena-Barrio ME; Navarro-Fernández J; Kristensen SR; Miñano A; Padilla J; Vicente V; Corral J
Thromb Res; 2011 Feb; 127(2):154-60. PubMed ID: 21126754
[TBL] [Abstract][Full Text] [Related]
9. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of synthetic pentasaccharide, low-molecular-weight heparin, unfractionated heparin and recombinant hirudin on the generation of factor VIIa and prothrombin activation after coagulation of human plasma.
Gerotziafas GT; Bara L; Bloch MF; Makris PE; Samama MM
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):571-80. PubMed ID: 9863704
[TBL] [Abstract][Full Text] [Related]
11. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.
Lupu C; Poulsen E; Roquefeuil S; Westmuckett AD; Kakkar VV; Lupu F
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2251-62. PubMed ID: 10479670
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor.
Altman R; Scazziota A; Rouvier J
Haemostasis; 1998; 28(5):229-35. PubMed ID: 10420071
[TBL] [Abstract][Full Text] [Related]
13. The effect of heparin and its neutralisation on functional assays for factor VIIa, factor VII and TFPI.
Cardigan RA; Mackie IJ; Machin SJ
Thromb Res; 1996 Nov; 84(4):237-42. PubMed ID: 8948048
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
15. Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins.
Bendz B; Hansen JB; Andersen TO; Ostergaard P; Sandset PM
Br J Haematol; 1999 Dec; 107(4):756-62. PubMed ID: 10606880
[TBL] [Abstract][Full Text] [Related]
16. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor.
Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L
J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255
[TBL] [Abstract][Full Text] [Related]
17. Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor?
Jacobsen EM; Sandset PM; Wisløff F
Thromb Res; 1999 May; 94(4):213-20. PubMed ID: 10336236
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins.
Alban S; Gastpar R
Thromb Haemost; 2001 May; 85(5):824-9. PubMed ID: 11372675
[TBL] [Abstract][Full Text] [Related]
19. Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.
Naumnik B; Borawski J; Myśliwiec M
Nephrol Dial Transplant; 2003 Jul; 18(7):1376-82. PubMed ID: 12808176
[TBL] [Abstract][Full Text] [Related]
20. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface.
Ghosh S; Ezban M; Persson E; Pendurthi U; Hedner U; Rao LV
J Thromb Haemost; 2007 Feb; 5(2):336-46. PubMed ID: 17092304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]